Life Sciences

Antidepressant lawsuits against GSK, Pfizer back on

Pharma Compliance Alert, March 18, 2009

Pharmaceutical companies are already seeing the fallout from the Supreme Court’s decision permitting patients to sue under state product liability laws.

The Supreme Court ruled March 4 that FDA approval does not shield pharmaceutical manufacturers from patient lawsuits. The following week the Supreme Court ordered U.S. Court of Appeals for the Third Circuit in Philadelphia to reexamine lawsuits against GlaxoSmithKline (GSK) and Pfizer, according to the Associated Press.

GSK and Pfizer failed to warn consumers that their antidepressants Paxil and Zoloft could increase the risk of suicide in adults, according to the lawsuits. The Appeals Court initially ruled that the FDA concluded suicide warnings for adults would be misleading.

Most Popular